Shawn Jindal
Hematology · Springfield, NJNPI 1437654944
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.7% of the total across 80 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 13.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,216, 4.7 times the $257 reported in 2023.
Across 80 payments — averaging $28.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$315
- Exelixis Inc.$308
- Novartis$240
- AbbVie$214
- EMD Serono, Inc.$167
- AstraZeneca$137
- plus $929 from 28 others
What the payments were for
- Food & beverage$2,21096%
- Education$994%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 5 | $315 |
| Exelixis Inc. | 2 | $308 |
| Novartis | 8 | $240 |
| AbbVie | 8 | $214 |
| EMD Serono, Inc. | 2 | $167 |
| AstraZeneca | 8 | $137 |
| Daiichi Sankyo Inc. | 3 | $74 |
| Pfizer | 4 | $66 |
| Taiho Oncology, Inc. | 3 | $63 |
| Genmab U.S., Inc. | 3 | $59 |
| Sanofi | 3 | $58 |
| AVEO Pharmaceuticals, Inc. | 2 | $56 |
| GSK | 3 | $55 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $42 |
| Incyte Corporation | 2 | $41 |
| Servier Pharmaceuticals LLC | 2 | $38 |
| Jazz Pharmaceuticals Inc. | 2 | $37 |
| Johnson & Johnson | 2 | $37 |
| Novocure Inc. | 1 | $28 |
| Tempus AI, Inc | 1 | $27 |
| Bayer | 1 | $23 |
| Genentech USA, Inc. | 1 | $22 |
| Beigene USA, Inc. | 1 | $21 |
| Cycle Pharmaceuticals Inc | 1 | $19 |
| Mirati Therapeutics, Inc. | 1 | $19 |
| Blueprint Medicines Corporation | 1 | $19 |
| Deciphera Pharmaceuticals Inc. | 1 | $18 |
| ADC Therapeutics America, Inc. | 1 | $17 |
| Bristol Myers Squibb | 1 | $17 |
| Sobi, Inc | 1 | $16 |
| Adaptive Biotechnologies Corporation | 1 | $15 |
| Puma Biotechnology, Inc. | 1 | $15 |
| Merck | 1 | $15 |
| Tactile Systems Technology Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,309 in reported general payments places this provider in the 55th percentile of 43 hematology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisone | 18 | $63 |
| Famotidine | 12 | $32 |
Paid to pharmacies, not to this prescriber.
Other hematology in Springfield
- Ahmed GalalMorristown$1.7M
- Mansi ShahNew Brunswick$131K
- Fermina MazzellaNewark$49K
- Muhammad AbbasiMountain Lakes$22K
- Robert TassanWestwood$21K
- Marcus CarrNorth Brunswick$19K
- Jason LevitzMountain Lakes$19K
- Christopher TullyMountain Lakes$17K
- Claire PhilippNew Brunswick$17K
- Tiffany PompaMarmora$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.